NCT06481826 2026-03-27
Glofitamab in Chinese Patients With R/R DLBCL
Peking Union Medical College Hospital
Recruiting
Clinical Trials
6 trialsNCT07057765 2025-07-10
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Ain Shams University
Recruiting
NCT05377307 2025-05-13
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Pell Bio-Med Technology Co., Ltd.
Recruiting
NCT06026488 2024-12-19
Real-World Study of DLBCL With Different Genetic Subtypes
Ruijin Hospital
Recruiting
NCT06526065 2024-07-29
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
University Medical Center Goettingen
Recruiting
NCT06299553 2024-05-22
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Incyte Biosciences Italy S.r.l
Recruiting